Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.945 USD | -1.63% | -5.87% | -11.72% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Business Summary
Number of employees: 14
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
INKmune and DN-TNF Product Platform
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -58.56% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -58.56% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Moss
FOU | Founder | 54 | 15-08-31 |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Tara Lehner
CTO | Chief Tech/Sci/R&D Officer | - | - |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marcia Allen
BRD | Director/Board Member | 73 | 19-11-18 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Scott Juda
BRD | Director/Board Member | 53 | 18-03-12 |
Director/Board Member | 64 | 19-08-07 | |
J. Ganjei
BRD | Director/Board Member | 50 | 16-08-31 |
David Moss
FOU | Founder | 54 | 15-08-31 |
Director/Board Member | 66 | 16-11-30 | |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,782,429 | 13,419,602 ( 67.84 %) | 0 | 67.84 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.72% | 200M | |
+9.88% | 118B | |
+9.93% | 106B | |
-11.22% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.59% | 15.97B | |
+6.69% | 14.03B | |
+16.15% | 11.67B |
- Stock Market
- Equities
- INMB Stock
- Company INmune Bio, Inc.